Literature DB >> 31959969

Culture-enriched metagenomic sequencing enables in-depth profiling of the cystic fibrosis lung microbiota.

Fiona J Whelan1, Barbara Waddell2, Saad A Syed3, Shahrokh Shekarriz3, Harvey R Rabin2,4, Michael D Parkins2,4, Michael G Surette5,6,7.   

Abstract

Amplicon sequencing (for example, of the 16S rRNA gene) identifies the presence and relative abundance of microbial community members. However, metagenomic sequencing is needed to identify the genetic content and functional potential of a community. Metagenomics is challenging in samples dominated by host DNA, such as those from the skin, tissue and respiratory tract. Here, we combine advances in amplicon and metagenomic sequencing with culture-enriched molecular profiling to study the human microbiota. Using the cystic fibrosis lung as an example, we cultured an average of 82.13% of the operational taxonomic units representing 99.3% of the relative abundance identified in direct sequencing of sputum samples; importantly, culture enrichment identified 63.3% more operational taxonomic units than direct sequencing. We developed the PLate Coverage Algorithm (PLCA) to determine a representative subset of culture plates on which to conduct culture-enriched metagenomics, resulting in the recovery of greater taxonomic diversity-including of low-abundance taxa-with better metagenome-assembled genomes, longer contigs and better functional annotations when compared to culture-independent methods. The PLCA is also applied as a proof of principle to a previously published gut microbiota dataset. Culture-enriched molecular profiling can be used to better understand the role of the human microbiota in health and disease.

Entities:  

Mesh:

Year:  2020        PMID: 31959969     DOI: 10.1038/s41564-019-0643-y

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  76 in total

Review 1.  Unravelling the effects of the environment and host genotype on the gut microbiome.

Authors:  Aymé Spor; Omry Koren; Ruth Ley
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

2.  Dysbiosis is not an answer.

Authors:  Scott W Olesen; Eric J Alm
Journal:  Nat Microbiol       Date:  2016-11-25       Impact factor: 17.745

3.  Microbial culturomics: paradigm shift in the human gut microbiome study.

Authors:  J-C Lagier; F Armougom; M Million; P Hugon; I Pagnier; C Robert; F Bittar; G Fournous; G Gimenez; M Maraninchi; J-F Trape; E V Koonin; B La Scola; D Raoult
Journal:  Clin Microbiol Infect       Date:  2012-10-03       Impact factor: 8.067

4.  Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria.

Authors:  Elizabeth A Rettedal; Heidi Gumpert; Morten O A Sommer
Journal:  Nat Commun       Date:  2014-08-28       Impact factor: 14.919

5.  The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice.

Authors:  Peter J Turnbaugh; Vanessa K Ridaura; Jeremiah J Faith; Federico E Rey; Rob Knight; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2009-11-11       Impact factor: 17.956

6.  Effect of diet on human fecal flora: comparison of Japanese and American diets.

Authors:  S M Finegold; H R Attebery; V L Sutter
Journal:  Am J Clin Nutr       Date:  1974-12       Impact factor: 7.045

7.  Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice.

Authors:  Andrew L Goodman; George Kallstrom; Jeremiah J Faith; Alejandro Reyes; Aimee Moore; Gautam Dantas; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

8.  Environment dominates over host genetics in shaping human gut microbiota.

Authors:  Daphna Rothschild; Omer Weissbrod; Elad Barkan; Alexander Kurilshikov; Tal Korem; David Zeevi; Paul I Costea; Anastasia Godneva; Iris N Kalka; Noam Bar; Smadar Shilo; Dar Lador; Arnau Vich Vila; Niv Zmora; Meirav Pevsner-Fischer; David Israeli; Noa Kosower; Gal Malka; Bat Chen Wolf; Tali Avnit-Sagi; Maya Lotan-Pompan; Adina Weinberger; Zamir Halpern; Shai Carmi; Jingyuan Fu; Cisca Wijmenga; Alexandra Zhernakova; Eran Elinav; Eran Segal
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

9.  Diversity is the question, not the answer.

Authors:  Ashley Shade
Journal:  ISME J       Date:  2016-09-16       Impact factor: 10.302

10.  Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling.

Authors:  Jennifer T Lau; Fiona J Whelan; Isiri Herath; Christine H Lee; Stephen M Collins; Premysl Bercik; Michael G Surette
Journal:  Genome Med       Date:  2016-07-01       Impact factor: 11.117

View more
  16 in total

1.  A complete and flexible workflow for metaproteomics data analysis based on MetaProteomeAnalyzer and Prophane.

Authors:  Henning Schiebenhoefer; Kay Schallert; Bernhard Y Renard; Kathrin Trappe; Emanuel Schmid; Dirk Benndorf; Katharina Riedel; Thilo Muth; Stephan Fuchs
Journal:  Nat Protoc       Date:  2020-08-28       Impact factor: 13.491

2.  Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis.

Authors:  Tara Gallagher; Stefan Riedel; Joseph Kapcia; Lindsay J Caverly; Lisa Carmody; Linda M Kalikin; Junnan Lu; Joann Phan; Matthew Gargus; Miki Kagawa; Simon W Leemans; Jason A Rothman; Felix Grun; John J LiPuma; Katrine L Whiteson
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

Review 3.  State of the Art in the Culture of the Human Microbiota: New Interests and Strategies.

Authors:  Maryam Tidjani Alou; Sabrina Naud; Saber Khelaifia; Marion Bonnet; Jean-Christophe Lagier; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2020-10-28       Impact factor: 26.132

4.  Microbiome Data Enhances Predictive Models of Lung Function in People With Cystic Fibrosis.

Authors:  Conan Y Zhao; Yiqi Hao; Yifei Wang; John J Varga; Arlene A Stecenko; Joanna B Goldberg; Sam P Brown
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

Review 5.  The lung microbiome: progress and promise.

Authors:  Samantha A Whiteside; John E McGinniss; Ronald G Collman
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

6.  Marine Sponge Endosymbionts: Structural and Functional Specificity of the Microbiome within Euryspongia arenaria Cells.

Authors:  Qi Yang; Jackson K B Cahn; Jörn Piel; Yue-Fan Song; Wei Zhang; Hou-Wen Lin
Journal:  Microbiol Spectr       Date:  2022-05-02

7.  Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.

Authors:  Jeffrey M Flynn; Lydia C Cameron; Talia D Wiggen; Jordan M Dunitz; William R Harcombe; Ryan C Hunter
Journal:  mSphere       Date:  2020-04-29       Impact factor: 4.389

8.  The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi.

Authors:  Otávio Guilherme Gonçalves de Almeida; Carolina Paulino da Costa Capizzani; Ludmilla Tonani; Patrícia Helena Grizante Barião; Anderson Ferreira da Cunha; Elaine Cristina Pereira De Martinis; Lidia Alice Gomes Monteiro Marin Torres; Marcia Regina von Zeska Kress
Journal:  Front Cell Infect Microbiol       Date:  2020-11-11       Impact factor: 5.293

9.  A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.

Authors:  Sudip Das; Eric Bernasconi; Angela Koutsokera; Daniel-Adrien Wurlod; Vishwachi Tripathi; Germán Bonilla-Rosso; John-David Aubert; Marie-France Derkenne; Louis Mercier; Céline Pattaroni; Alexis Rapin; Christophe von Garnier; Benjamin J Marsland; Philipp Engel; Laurent P Nicod
Journal:  Nat Commun       Date:  2021-04-09       Impact factor: 14.919

10.  One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway.

Authors:  Fabrice Jean-Pierre; Arsh Vyas; Thomas H Hampton; Michael A Henson; George A O'Toole
Journal:  mBio       Date:  2021-03-16       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.